Mr Jeffrey David Pearce, MD | |
1357 Oconee Connector Bldg 300, Watkinsville, GA 30677-7314 | |
(706) 549-8306 | |
Not Available |
Full Name | Mr Jeffrey David Pearce |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 24 Years |
Location | 1357 Oconee Connector Bldg 300, Watkinsville, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538134978 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 200200767 (North Carolina) | Secondary |
208600000X | Surgery | 200200767 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Piedmont Athens Regional Medical Center | Athens, GA | Hospital |
St Mary's Hospital | Athens, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Surgical Associates Of Athens | 2668463290 | 12 |
News Archive
Syndax Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has designated entinostat as a Breakthrough Therapy for the treatment of locally recurrent or metastatic estrogen receptor-positive (ER+) breast cancer when added to exemestane in postmenopausal women whose disease has progressed following non-steroidal aromatase inhibitor therapy.
A subgroup of patients with osteosarcoma - a form of bone cancer - could be helped by an existing drug, suggest scientists from the Wellcome Trust Sanger Institute and their collaborators at University College London Cancer Institute and the Royal National Orthopaedic Hospital NHS Trust.
Two of the most powerful approaches to cancer treatment - a stem cell transplant and an immune system-stimulating vaccine - appear to reinforce each other in patients with an aggressive, hard-to-control form of leukemia, Dana-Farber Cancer Institute scientists have found.
The Board of Directors of Tyco International Ltd. today declared a quarterly dividend of 0.22 Swiss Francs (CHF) per share, payable on May 26, 2010 to shareholders of record at the close of business on April 30, 2010, subject to a required filing with the Swiss Commercial Register.
Despite promising advances, important scientific questions remain unanswered in the effort to develop a safe and effective Ebola vaccine, according to members of an international Ebola research consortium.
› Verified 1 days ago
Entity Name | Piedmont Athens Regional Medical Center, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437186111 PECOS PAC ID: 6800784067 Enrollment ID: O20040309000481 |
News Archive
Syndax Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has designated entinostat as a Breakthrough Therapy for the treatment of locally recurrent or metastatic estrogen receptor-positive (ER+) breast cancer when added to exemestane in postmenopausal women whose disease has progressed following non-steroidal aromatase inhibitor therapy.
A subgroup of patients with osteosarcoma - a form of bone cancer - could be helped by an existing drug, suggest scientists from the Wellcome Trust Sanger Institute and their collaborators at University College London Cancer Institute and the Royal National Orthopaedic Hospital NHS Trust.
Two of the most powerful approaches to cancer treatment - a stem cell transplant and an immune system-stimulating vaccine - appear to reinforce each other in patients with an aggressive, hard-to-control form of leukemia, Dana-Farber Cancer Institute scientists have found.
The Board of Directors of Tyco International Ltd. today declared a quarterly dividend of 0.22 Swiss Francs (CHF) per share, payable on May 26, 2010 to shareholders of record at the close of business on April 30, 2010, subject to a required filing with the Swiss Commercial Register.
Despite promising advances, important scientific questions remain unanswered in the effort to develop a safe and effective Ebola vaccine, according to members of an international Ebola research consortium.
› Verified 1 days ago
Entity Name | University Surgical Associates Of Athens |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861500183 PECOS PAC ID: 2668463290 Enrollment ID: O20040521000292 |
News Archive
Syndax Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has designated entinostat as a Breakthrough Therapy for the treatment of locally recurrent or metastatic estrogen receptor-positive (ER+) breast cancer when added to exemestane in postmenopausal women whose disease has progressed following non-steroidal aromatase inhibitor therapy.
A subgroup of patients with osteosarcoma - a form of bone cancer - could be helped by an existing drug, suggest scientists from the Wellcome Trust Sanger Institute and their collaborators at University College London Cancer Institute and the Royal National Orthopaedic Hospital NHS Trust.
Two of the most powerful approaches to cancer treatment - a stem cell transplant and an immune system-stimulating vaccine - appear to reinforce each other in patients with an aggressive, hard-to-control form of leukemia, Dana-Farber Cancer Institute scientists have found.
The Board of Directors of Tyco International Ltd. today declared a quarterly dividend of 0.22 Swiss Francs (CHF) per share, payable on May 26, 2010 to shareholders of record at the close of business on April 30, 2010, subject to a required filing with the Swiss Commercial Register.
Despite promising advances, important scientific questions remain unanswered in the effort to develop a safe and effective Ebola vaccine, according to members of an international Ebola research consortium.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Jeffrey David Pearce, MD 1357 Oconee Connector Bldg 300, Watkinsville, GA 30677-7314 Ph: (706) 549-8306 | Mr Jeffrey David Pearce, MD 1357 Oconee Connector Bldg 300, Watkinsville, GA 30677-7314 Ph: (706) 549-8306 |
News Archive
Syndax Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has designated entinostat as a Breakthrough Therapy for the treatment of locally recurrent or metastatic estrogen receptor-positive (ER+) breast cancer when added to exemestane in postmenopausal women whose disease has progressed following non-steroidal aromatase inhibitor therapy.
A subgroup of patients with osteosarcoma - a form of bone cancer - could be helped by an existing drug, suggest scientists from the Wellcome Trust Sanger Institute and their collaborators at University College London Cancer Institute and the Royal National Orthopaedic Hospital NHS Trust.
Two of the most powerful approaches to cancer treatment - a stem cell transplant and an immune system-stimulating vaccine - appear to reinforce each other in patients with an aggressive, hard-to-control form of leukemia, Dana-Farber Cancer Institute scientists have found.
The Board of Directors of Tyco International Ltd. today declared a quarterly dividend of 0.22 Swiss Francs (CHF) per share, payable on May 26, 2010 to shareholders of record at the close of business on April 30, 2010, subject to a required filing with the Swiss Commercial Register.
Despite promising advances, important scientific questions remain unanswered in the effort to develop a safe and effective Ebola vaccine, according to members of an international Ebola research consortium.
› Verified 1 days ago
Dr. Christopher Brian Everett, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1357 Oconee Connector Bldg 300, Watkinsville, GA 30677 Phone: 706-549-8306 | |
Dr. David Mathis Sailors, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1357 Oconee Connector Bldg 300, Watkinsville, GA 30677 Phone: 706-549-8306 Fax: 706-549-8351 | |
Dr. Howard Teasley Abney, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 33 Harden Hill Rd, Watkinsville, GA 30677 Phone: 706-769-7625 | |
Dr. Jonathan Dewey Woody, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1357 Oconee Connector Bldg 300, Watkinsville, GA 30677 Phone: 706-549-8306 Fax: 706-549-8351 |